Supplemental material: Allometric Scaling of Testosterone Enanthate Pharmacokinetics to Adolescent Hypogonadal Males (IM and SC Administration)

Published: 20 March 2023| Version 1 | DOI: 10.17632/rzdmvymc8w.1
Contributors:
,
,
,

Description

Supplemental Figure 1: Simulated Individual Predictions for the SC TE Model p3 Supplemental Figure 2: Simulated Individual Predictions for the IM TE Model p4 Supplemental Figure 3: Goodness of Fit for the SC TE Model p5 Supplemental Figure 4: Goodness of Fit for the IM TE Model p6 Supplemental Figure 5: Visual Predictive Check of the SC TE Model p7 Supplemental Figure 6: Visual Predictive Check of the IM TE Model p8 Supplemental Figure 7: Simulated Population (Mean) Predictions for the SC TE Model p9 Supplemental Figure 8: Simulated Population (Mean) Predictions for the IM TE Model p10 Supplemental Table 1: Comparison of Evaluated Compartmental Models and Error Models for the SC TE Model p11 Supplemental Table 2: Comparison of Evaluated Compartmental Models and Error Models for the IM TE Model p12 Supplemental Table 3: Comparison of Final Parameters of SC and IM TE Models p13 Supplemental Table 4: Bootstrap Analysis of the SC TE Model p14 Supplemental Table 5: Bootstrap Analysis of the IM TE Model p15

Files

Institutions

Synteract Inc, Children's Hospital of Philadelphia, Antares Pharma Inc, University of Virginia

Categories

Pharmacokinetics, Testosterone, Allometry

Funding

Antares Pharma Inc.

Licence